Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
Sales | 269 | 352 | 396 | 442 | 318 |
Gross Profit | 269 | 352 | 396 | 442 | 318 |
Operating Expenses | 6,963 | 3,659 | 3,764 | 3,816 | 3,969 |
Operating Income | -6,694 | -3,307 | -3,368 | -3,374 | -3,651 |
Pre-tax Income | -6,694 | -3,307 | -3,368 | -3,374 | -3,651 |
Net Income Continuous | -6,694 | -3,307 | -3,368 | -3,374 | -3,651 |
Net Income | $-6,694 | $-3,307 | $-3,368 | $-3,374 | $-3,651 |
EPS Basic Total Ops | -2.08 | -1.04 | -1.04 | -1.04 | -1.24 |
EPS Basic Continuous Ops | -2.10 | -1.02 | -1.05 | -1.06 | -1.24 |
EPS Diluted Total Ops | -2.08 | -1.04 | -1.04 | -1.04 | -1.24 |
EPS Diluted Continuous Ops | -2.10 | -1.02 | -1.05 | -1.06 | -1.24 |
EBITDA(a) | $-6,685 | $-3,298 | $-3,359 | $-3,366 | $-3,643 |